Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Conversation logo

Cognitive behavioural therapy (CBT) is one of the most common treatments for many different mental health conditions. This talking therapy aims to help people by identifying unhelpful thoughts and patterns of behaviour and promoting new ways of thinking. It’s used to treat a variety of common conditions, such as anxiety and depression – and is even used to help manage physical health conditions, such as chronic pain, cancer and diabetes.

CBT is also the most researched psychological therapy in the world. Once it was shown to be helpful for one condition, researchers began testing it across many others. But though plenty of time, money, and resources have been put into investigating the effectiveness of CBT, our recent study has shown that only a small proportion of the research is known to have included data from non-white ethnic groups. This means we may not fully know if CBT actually does work equally well for people from different ethnic groups, religions and cultural groups.

Read the full article on The Conversation website, written by Beth Fordham (Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences)

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

Athena Swan Gold Award success for Nuffield Department of Primary Care Health Sciences

The award reflects the Department’s commitment to representation, progression and success for all. It acknowledges the innovative policies and practices developed across the department and the detailed action plans for improvement.

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Professor Sir Chris Whitty brings greater understanding of epidemics to Oxford

Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.

Multiple Debilitating Pains – New global study shows the experience of Endometriosis is rooted in a person’s genetics

Researchers at the University of Oxford in collaboration with 25 teams across the world have published the largest study to date of the genetic basis of endometriosis.

Study shows delaying treatment for localised prostate cancer does not increase mortality risk

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.